The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen.

A new evaluation of the Olink Explore 3072 proximity extension assay in cerebrospinal fluid finds that protein detectability ...

New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute ...

Deep Mito brine assays strengthen Pursuit's case for a bigger Rio Grande Sur resource. ... Read More The post Pursuit ...

AnteoTech (ASX:ADO) is classified by the Australian Securities Exchange as a materials company but part of its offering sits ...

Mabtech AB, a Swedish developer of immunoassays and instruments for life science research, today announced that its complete product ...

A new mass spectrometry assay identifies patient-specific M-protein peptides in plasma without sequencing, showing generally ...

Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter revenue of $200,000 as it continued its transition toward ...

The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is ...

MammoLink joins Mammogen’s KATELYN-ERIN trial, expanding community access to a prospective study evaluating blood-based RNA biology for breast cancer detection ...

Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and ...

Edge Copper Corporation was pleased to announce the appointment of Chris Ballard as Vice President of Exploration, effective November 1, 2026. Mr. Ballard brings direct experience at the Company's 100 ...